FindTrial
Sign In

Lignocaine(alkalinised) versus dexamethasone in prevention of post operative sore throat after general anesthesia

Alkalinized lignocaine versus dexmethasone in prevention of postoperative sore throat after general anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046670
Enrollment
111
Registered
2022-10-20
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Group D intracuff dexamethasone: Dexamethasone 0.1mg/kg and saline (total volume -6ml) Intervention2: Group L intracuff lignocaine: Intracuff lignocaine 2% (2ml) and 7.5% sodium bicarbo

Sponsors

Suvina N
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing elective surgery of less than or equal to 2 hours Patients of ASA 1 and 2

Exclusion criteria

Exclusion criteria: Pregnant women Chronic smoker BMI 40 Patients with upper respiratory tract infections of less than 1 month Patients with anticipated difficult airway

Design outcomes

Primary

MeasureTime frame
Study the effects of intracuff air, alkalinised lignocaine and dexamethasone on incidence of post operative sore throat Tube toleranceTimepoint: 30min , 60 min , 90min , 120 min , post op 1st , 6th , 12th , 24th hr—

Secondary

MeasureTime frame
Incidence of cough and hoarseness of voice.Timepoint: Post op 1st , 6th,12 12th and 24th hr—

Countries

India

Contacts

Public ContactSuvina N

Vydehi Institute of Medical Sciences

suvi11492@gmail.com6366279888

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026